Aridis Pharmaceuticals Inc (NASDAQ:ARDS)

Delayed Data
As of May 26
 +0.0035 / +1.93%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Aridis Pharmaceuticals Inc have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 2.00. The median estimate represents a +1,016.69% increase from the last price of 0.18.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Aridis Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly --
Growthannually 20.12%


Growthquarterly --
Growthannually -34.87%
Key to the earnings and sales forecast charts.